Search research articles
Contact Us
Filters
Showing results (101-110 of 119) with videos related to
Page
of 12
Sort By:
Familial Cancer
|
March 13, 2013
Novel and recurrent BRCA1/BRCA2 mutations in early onset and familial breast and ovarian cancer detected in the Program of Genetic Counseling in Cancer of Valencian Community (eastern Spain). Relationship of family phenotypes with mutation prevalence
Inmaculada de Juan Jiménez, Zaida García Casado, Sarai Palanca Suela, et al.
Medicina
|
January 17, 2022
[Structural capacity, technological human resources and mechanical ventilation requirements in 58 intensive care units in Argentina during the SARS-CoV-2 pandemic. A SATICOVID-19 Study]
Elisa Estenssoro, Gustavo Plotnikow, Cecilia I Loudet, et al.
Cancers
|
April 23, 2022
Prospective Real-World Gynaecological Cancer Clinical Registry with Associated Biospecimens: A Collaborative Model to Promote Translational Research between GEICO and the Spanish Biobank Network
José Antonio López-Guerrero, Marta Mendiola, José Alejandro Pérez-Fidalgo, et al.
Molecular Oncology
|
April 1, 2021
The evolutionarily conserved long non-coding RNA LINC00261 drives neuroendocrine prostate cancer proliferation and metastasis via distinct nuclear and cytoplasmic mechanisms
Rebecca L Mather, Abhijit Parolia, Sandra E Carson, et al.
Clinical Therapeutics
|
July 17, 2024
Niraparib Population Pharmacokinetics and Exposure-Response Relationships in Patients With Newly Diagnosed Advanced Ovarian Cancer
Bradley J Monk, Ignacio Romero, Whitney Graybill, et al.
International Journal of Molecular Sciences
|
June 28, 2023
Assessment of Tissue Expression of the Oxytocin-Vasopressin Pathway in the Placenta of Women with a First-Episode Psychosis during Pregnancy
Miguel A Ortega, Cielo García-Montero, Óscar Fraile-Martinez, et al.
Journal of Personalized Medicine
|
December 29, 2022
Laboratory Cross-Comparison and Ring Test Trial for Tumor <i>BRCA</i> Testing in a Multicenter Epithelial Ovarian Cancer Series: The BORNEO GEICO 60-0 Study
Zaida Garcia-Casado, Ana Oaknin, Marta Mendiola, et al.
Cancers
|
June 10, 2023
The Scarface Score: Deciphering Response to DNA Damage Agents in High-Grade Serous Ovarian Cancer-A GEICO Study
Antonio Fernández-Serra, Raquel López-Reig, Raúl Márquez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 3, 2025
Atezolizumab With Bevacizumab and Nonplatinum Chemotherapy for Recurrent Ovarian Cancer: Final Results From the Placebo-Controlled AGO-OVAR 2.29/ENGOT-ov34 Phase III Trial
Philipp Harter, Frederik Marmé, Andrés Redondo, et al.
Lancet (London, England)
|
December 4, 2023
Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial
Ana Oaknin, Laurence Gladieff, Jerónimo Martínez-García, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 119) with videos related to
Sort By:
Page
of 12
Familial Cancer
|
March 13, 2013
Novel and recurrent BRCA1/BRCA2 mutations in early onset and familial breast and ovarian cancer detected in the Program of Genetic Counseling in Cancer of Valencian Community (eastern Spain). Relationship of family phenotypes with mutation prevalence
Inmaculada de Juan Jiménez, Zaida García Casado, Sarai Palanca Suela, et al.
Medicina
|
January 17, 2022
[Structural capacity, technological human resources and mechanical ventilation requirements in 58 intensive care units in Argentina during the SARS-CoV-2 pandemic. A SATICOVID-19 Study]
Elisa Estenssoro, Gustavo Plotnikow, Cecilia I Loudet, et al.
Cancers
|
April 23, 2022
Prospective Real-World Gynaecological Cancer Clinical Registry with Associated Biospecimens: A Collaborative Model to Promote Translational Research between GEICO and the Spanish Biobank Network
José Antonio López-Guerrero, Marta Mendiola, José Alejandro Pérez-Fidalgo, et al.
Molecular Oncology
|
April 1, 2021
The evolutionarily conserved long non-coding RNA LINC00261 drives neuroendocrine prostate cancer proliferation and metastasis via distinct nuclear and cytoplasmic mechanisms
Rebecca L Mather, Abhijit Parolia, Sandra E Carson, et al.
Clinical Therapeutics
|
July 17, 2024
Niraparib Population Pharmacokinetics and Exposure-Response Relationships in Patients With Newly Diagnosed Advanced Ovarian Cancer
Bradley J Monk, Ignacio Romero, Whitney Graybill, et al.
International Journal of Molecular Sciences
|
June 28, 2023
Assessment of Tissue Expression of the Oxytocin-Vasopressin Pathway in the Placenta of Women with a First-Episode Psychosis during Pregnancy
Miguel A Ortega, Cielo García-Montero, Óscar Fraile-Martinez, et al.
Journal of Personalized Medicine
|
December 29, 2022
Laboratory Cross-Comparison and Ring Test Trial for Tumor <i>BRCA</i> Testing in a Multicenter Epithelial Ovarian Cancer Series: The BORNEO GEICO 60-0 Study
Zaida Garcia-Casado, Ana Oaknin, Marta Mendiola, et al.
Cancers
|
June 10, 2023
The Scarface Score: Deciphering Response to DNA Damage Agents in High-Grade Serous Ovarian Cancer-A GEICO Study
Antonio Fernández-Serra, Raquel López-Reig, Raúl Márquez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 3, 2025
Atezolizumab With Bevacizumab and Nonplatinum Chemotherapy for Recurrent Ovarian Cancer: Final Results From the Placebo-Controlled AGO-OVAR 2.29/ENGOT-ov34 Phase III Trial
Philipp Harter, Frederik Marmé, Andrés Redondo, et al.
Lancet (London, England)
|
December 4, 2023
Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial
Ana Oaknin, Laurence Gladieff, Jerónimo Martínez-García, et al.
Page
of 12